Who invested in Redx Pharma?
Redx Pharma's investors include Sofinnova Partners, European Commission and Redmile Group.

United Kingdom · Series A startup
Funding summaryUpdated 26 Oct 2026
$127Mraised across 5 rounds since 2021, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Redx Pharma filed 6 raises, $126M in all. Filings say how much was sold and to how many investors; they never name the investors.
From Redx Pharma's own website: 9 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Redx Pharma's investors include Sofinnova Partners, European Commission and Redmile Group.
Redx Pharma has raised $127M across 5 rounds since 2021.
Redx Pharma's most recent round was a Series A of $59M in Aug 2026.
Its most recent round, $59M in Aug 2026, is also its largest on record.
Redx Pharma's first round on record, in May 2022, was backed by Sofinnova Partners, European Commission and Redmile Group.
Redx Pharma's latest named round is a Series A, in Aug 2026.
Redx Pharma is based in the United Kingdom.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.